Global Nasal Drug Delivery Market, By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others), By Dosage Form (Sprays, Drops, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Metered Dose, Multi-Dose, Unit Dose), By Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion), By End User (Home Care Settings, Hospitals, Clinics), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2026
Global nasal drug delivery market is expected to grow at CAGR of 11.67% during the forecast period and is projected to reach USD123.92 billion by 2026 owing to the growing cases of respiratory problems such as asthma, paranasal sinuses, nasal infection, and others along with surging demand for non-invasive techniques and less painful treatments. Nasal drug delivery devices provide self-medication, which does not require patients to visit the doctor. The growing adoption of self-administration practices and demand for home healthcare devices are acting as key growth drivers for the growth of the global nasal drug delivery market. Furthermore, development of advanced nasal drug delivery devices and their efficacy and easy administration properties are propeling the market growth. With growing awareness and growing patient preference for nasal products, the market is poised to witness substantial growth in the next five years.
Moreover, increasing expenditure on healthcare sector and various governments’ focus on promoting R&D activities are supporting the growth of the global nasal drug delivery market. However, the market is also facing some restraints. Complications related to the over usage of nasal powders and nasal sprays are likely to hamper the growth of the global nasal drug delivery market.
Global nasal drug delivery market can be segmented based on drug type, dosage form, container type, basis of system, therapeutic applications, end user, distribution channel and region. Based on container type, the market can be segmented into non-pressurized containers and pressurized containers. Among them, the non-pressurized containers are expected to undergo the fastest CAGR during the forecast period as they are mostly used in nasal sprays. Thus, the increasing demand for nasal sprays and growing prevalence of chronic diseases like asthma and diabetes are expected to contribute to the dominant share of non-pressurized containers through 2026.
Regionally, North America dominated the global nasal drug delivery market in 2020 and is further expected to continue its dominance during the forecast period. Increasing cases of respiratory disorders and presence of key market players are making North America a favorable market for nasal drug delivery. However, Asia Pacific is anticipated to undergo the fastest CAGR during the forecast period owing to rising awareness and prevalence of chronic and respiratory disorders in the region.
Major companies operating in the global nasal drug delivery market include GlaxoSmithKline Plc., Pfizer, Inc., AstraZeneca PLC, Novartis AG, Becton Dickson & Company, Promius Pharma LLC, 3M COMPANY, Johnson & Johnson Services, Inc., Sanofi S.A., Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Aegis Therapeutics, LLC, B.F. Ascher & Company, Inc., ENT Technologies Pty. Ltd. and AptarGroup, Inc., among others. Key market players are undergoing growth strategies like joint ventures and new product launches to strengthen their position in the global market.
Years considered for this report:
TechSci Research calculated global nasal drug delivery market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.
Key Target Audience:
Report Scope:
In this report, global nasal drug delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
ii. Mexico
iii. Canada
ii. France
iii. United Kingdom
iv. Italy
v. Spain
ii. China
iii. India
iv. South Korea
v. Australia
ii. Argentina
iii. Colombia
ii. Saudi Arabia
iii. UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global nasal drug delivery market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Moreover, increasing expenditure on healthcare sector and various governments’ focus on promoting R&D activities are supporting the growth of the global nasal drug delivery market. However, the market is also facing some restraints. Complications related to the over usage of nasal powders and nasal sprays are likely to hamper the growth of the global nasal drug delivery market.
Global nasal drug delivery market can be segmented based on drug type, dosage form, container type, basis of system, therapeutic applications, end user, distribution channel and region. Based on container type, the market can be segmented into non-pressurized containers and pressurized containers. Among them, the non-pressurized containers are expected to undergo the fastest CAGR during the forecast period as they are mostly used in nasal sprays. Thus, the increasing demand for nasal sprays and growing prevalence of chronic diseases like asthma and diabetes are expected to contribute to the dominant share of non-pressurized containers through 2026.
Regionally, North America dominated the global nasal drug delivery market in 2020 and is further expected to continue its dominance during the forecast period. Increasing cases of respiratory disorders and presence of key market players are making North America a favorable market for nasal drug delivery. However, Asia Pacific is anticipated to undergo the fastest CAGR during the forecast period owing to rising awareness and prevalence of chronic and respiratory disorders in the region.
Major companies operating in the global nasal drug delivery market include GlaxoSmithKline Plc., Pfizer, Inc., AstraZeneca PLC, Novartis AG, Becton Dickson & Company, Promius Pharma LLC, 3M COMPANY, Johnson & Johnson Services, Inc., Sanofi S.A., Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Aegis Therapeutics, LLC, B.F. Ascher & Company, Inc., ENT Technologies Pty. Ltd. and AptarGroup, Inc., among others. Key market players are undergoing growth strategies like joint ventures and new product launches to strengthen their position in the global market.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022-2026
- To analyze and forecast the market size of the global nasal drug delivery market from 2016 to 2020.
- To estimate and forecast the market size of the global nasal drug delivery market from 2021 to 2026.
- To forecast global nasal drug delivery market based on drug type, dosage form, container type, basis of system, delivery technologies, therapeutic applications, end user, distribution channel, company and regional distribution.
- To identify drivers and challenges for global nasal drug delivery market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global nasal drug delivery market.
- To identify and analyze the profile of leading players operating in the global nasal drug delivery market.
TechSci Research calculated global nasal drug delivery market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.
Key Target Audience:
- Nasal Drug Delivery Market device manufacturers/ companies/ partners
- Hospital Pharmacies/ Retail Pharmacies
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to Nasal Drug Delivery Market
- Market research and consulting firms
Report Scope:
In this report, global nasal drug delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Nasal Drug Delivery Market, By Drug Type:
- Antihistamines
- Corticosteroids
- Anesthetics
- Antibiotics
- Pain Relief Drugs
- Others
- Global Nasal Drug Delivery Market, By Dosage Form:
- Sprays
- Drops
- Powder
- Gels & Ointments
- Global Nasal Drug Delivery Market, By Container Type:
- Non-pressurized Containers
- Pressurized Containers
- Global Nasal Drug Delivery Market, By Basis of System:
- Metered Dose
- Multi-Dose
- Unit Dose
- Global Nasal Drug Delivery Market, By Therapeutic Applications:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Rhinitis
- Cystic Fibrosis
- Nasal Congestion
- Global Nasal Drug Delivery Market, By End User:
- Home Care Settings
- Hospitals
- Clinics
- Global Nasal Drug Delivery Market, By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online
- Global Nasal Drug Delivery Market, By Region:
- North America
ii. Mexico
iii. Canada
- Europe
ii. France
iii. United Kingdom
iv. Italy
v. Spain
- Asia-Pacific
ii. China
iii. India
iv. South Korea
v. Australia
- South America
ii. Argentina
iii. Colombia
- Middle East & Africa
ii. Saudi Arabia
iii. UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global nasal drug delivery market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- Profit margin analysis in case of direct and indirect sales channel.
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Factors Influencing Purchase Decision
5.3. Patient Satisfaction Analysis
5.4. Unmet Need and Challenges
6. GLOBAL NASAL DRUG DELIVERY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others)
6.2.2. By Dosage Form (Sprays, Drops, Powder, Gels & Ointments)
6.2.3. By Container Type (Non-pressurized Containers, Pressurized Containers)
6.2.4. By Basis of System (Metered Dose, Multi-Dose, Unit Dose)
6.2.5. By Therapeutic Applications (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion)
6.2.6. By End User (Home Care Settings, Hospitals & Clinics)
6.2.7. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online)
6.2.8. By Company (2020)
6.2.9. By Region
6.3. Product Market Map
7. NORTH AMERICA NASAL DRUG DELIVERY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Dosage Form
7.2.3. By Container Type
7.2.4. By Basis of System
7.2.5. By Therapeutic Applications
7.2.6. By End User
7.2.7. By Distribution Channel
7.2.8. By Country
7.3. North America: Country Analysis
7.3.1. United States Nasal Drug Delivery Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Dosage Form
7.3.1.2.3. By Container Type
7.3.1.2.4. By Basis of System
7.3.1.2.5. By Therapeutic Applications
7.3.1.2.6. By End User
7.3.1.2.7. By Distribution Channel
7.3.2. Mexico Nasal Drug Delivery Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Dosage Form
7.3.2.2.3. By Container Type
7.3.2.2.4. By Basis of System
7.3.2.2.5. By Therapeutic Applications
7.3.2.2.6. By End User
7.3.2.2.7. By Distribution Channel
7.3.3. Canada Nasal Drug Delivery Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Dosage Form
7.3.3.2.3. By Container Type
7.3.3.2.4. By Basis of System
7.3.3.2.5. By Therapeutic Applications
7.3.3.2.6. By End User
7.3.3.2.7. By Distribution Channel
8. EUROPE NASAL DRUG DELIVERY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Dosage Form
8.2.3. By Container Type
8.2.4. By Basis of System
8.2.5. By Therapeutic Applications
8.2.6. By End User
8.2.7. By Distribution Channel
8.2.8. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nasal Drug Delivery Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Dosage Form
8.3.1.2.3. By Container Type
8.3.1.2.4. By Basis of System
8.3.1.2.5. By Therapeutic Applications
8.3.1.2.6. By End User
8.3.1.2.7. By Distribution Channel
8.3.2. France Nasal Drug Delivery Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Dosage Form
8.3.2.2.3. By Container Type
8.3.2.2.4. By Basis of System
8.3.2.2.5. By Therapeutic Applications
8.3.2.2.6. By End User
8.3.2.2.7. By Distribution Channel
8.3.3. United Kingdom Nasal Drug Delivery Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Dosage Form
8.3.3.2.3. By Container Type
8.3.3.2.4. By Basis of System
8.3.3.2.5. By Therapeutic Applications
8.3.3.2.6. By End User
8.3.3.2.7. By Distribution Channel
8.3.4. Italy Nasal Drug Delivery Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Dosage Form
8.3.4.2.3. By Container Type
8.3.4.2.4. By Basis of System
8.3.4.2.5. By Therapeutic Applications
8.3.4.2.6. By End User
8.3.4.2.7. By Distribution Channel
8.3.5. Spain Nasal Drug Delivery Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Dosage Form
8.3.5.2.3. By Container Type
8.3.5.2.4. By Basis of System
8.3.5.2.5. By Therapeutic Applications
8.3.5.2.6. By End User
8.3.5.2.7. By Distribution Channel
9. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Dosage Form
9.2.3. By Container Type
9.2.4. By Basis of System
9.2.5. By Therapeutic Applications
9.2.6. By End User
9.2.7. By Distribution Channel
9.2.8. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Japan Nasal Drug Delivery Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Dosage Form
9.3.1.2.3. By Container Type
9.3.1.2.4. By Basis of System
9.3.1.2.5. By Therapeutic Applications
9.3.1.2.6. By End User
9.3.1.2.7. By Distribution Channel
9.3.2. China Nasal Drug Delivery Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Dosage Form
9.3.2.2.3. By Container Type
9.3.2.2.4. By Basis of System
9.3.2.2.5. By Therapeutic Applications
9.3.2.2.6. By End User
9.3.2.2.7. By Distribution Channel
9.3.3. India Nasal Drug Delivery Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Dosage Form
9.3.3.2.3. By Container Type
9.3.3.2.4. By Basis of System
9.3.3.2.5. By Therapeutic Applications
9.3.3.2.6. By End User
9.3.3.2.7. By Distribution Channel
9.3.4. South Korea Nasal Drug Delivery Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Type
9.3.4.2.2. By Dosage Form
9.3.4.2.3. By Container Type
9.3.4.2.4. By Basis of System
9.3.4.2.5. By Therapeutic Applications
9.3.4.2.6. By End User
9.3.4.2.7. By Distribution Channel
9.3.5. Australia Nasal Drug Delivery Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Drug Type
9.3.5.2.2. By Dosage Form
9.3.5.2.3. By Container Type
9.3.5.2.4. By Basis of System
9.3.5.2.5. By Therapeutic Applications
9.3.5.2.6. By End User
9.3.5.2.7. By Distribution Channel
10. SOUTH AMERICA NASAL DRUG DELIVERY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Dosage Form
10.2.3. By Container Type
10.2.4. By Basis of System
10.2.5. By Therapeutic Applications
10.2.6. By End User
10.2.7. By Distribution Channel
10.2.8. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nasal Drug Delivery Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Dosage Form
10.3.1.2.3. By Container Type
10.3.1.2.4. By Basis of System
10.3.1.2.5. By Therapeutic Applications
10.3.1.2.6. By End User
10.3.1.2.7. By Distribution Channel
10.3.2. Argentina Nasal Drug Delivery Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Dosage Form
10.3.2.2.3. By Container Type
10.3.2.2.4. By Basis of System
10.3.2.2.5. By Therapeutic Applications
10.3.2.2.6. By End User
10.3.2.2.7. By Distribution Channel
10.3.3. Colombia Nasal Drug Delivery Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Dosage Form
10.3.3.2.3. By Container Type
10.3.3.2.4. By Basis of System
10.3.3.2.5. By Therapeutic Applications
10.3.3.2.6. By End User
10.3.3.2.7. By Distribution Channel
11. MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Dosage Form
11.2.3. By Container Type
11.2.4. By Basis of System
11.2.5. By Therapeutic Applications
11.2.6. By End User
11.2.7. By Distribution Channel
11.2.8. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Nasal Drug Delivery Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Dosage Form
11.3.1.2.3. By Container Type
11.3.1.2.4. By Basis of System
11.3.1.2.5. By Therapeutic Applications
11.3.1.2.6. By End User
11.3.1.2.7. By Distribution Channel
11.3.2. Saudi Arabia Nasal Drug Delivery Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Dosage Form
11.3.2.2.3. By Container Type
11.3.2.2.4. By Basis of System
11.3.2.2.5. By Therapeutic Applications
11.3.2.2.6. By End User
11.3.2.2.7. By Distribution Channel
11.3.3. UAE Nasal Drug Delivery Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Dosage Form
11.3.3.2.3. By Container Type
11.3.3.2.4. By Basis of System
11.3.3.2.5. By Therapeutic Applications
11.3.3.2.6. By End User
11.3.3.2.7. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. GlaxoSmithKline Plc.
14.2.2. Pfizer, Inc.
14.2.3. AstraZeneca PLC
14.2.4. Novartis AG
14.2.5. Becton Dickson & Company
14.2.6. Promius Pharma LLC
14.2.7. 3M Company
14.2.8. Johnson & Johnson Services, Inc.
14.2.9. Sanofi S.A.
14.2.10. Merck & Co., Inc.
14.2.11. Cadila Pharmaceuticals Ltd.
14.2.12. Aegis Therapeutics, LLC
14.2.13. B.F. Ascher & Company, Inc.
14.2.14. ENT Technologies Pty. Ltd.
14.2.15. AptarGroup, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Factors Influencing Purchase Decision
5.3. Patient Satisfaction Analysis
5.4. Unmet Need and Challenges
6. GLOBAL NASAL DRUG DELIVERY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others)
6.2.2. By Dosage Form (Sprays, Drops, Powder, Gels & Ointments)
6.2.3. By Container Type (Non-pressurized Containers, Pressurized Containers)
6.2.4. By Basis of System (Metered Dose, Multi-Dose, Unit Dose)
6.2.5. By Therapeutic Applications (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion)
6.2.6. By End User (Home Care Settings, Hospitals & Clinics)
6.2.7. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online)
6.2.8. By Company (2020)
6.2.9. By Region
6.3. Product Market Map
7. NORTH AMERICA NASAL DRUG DELIVERY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Dosage Form
7.2.3. By Container Type
7.2.4. By Basis of System
7.2.5. By Therapeutic Applications
7.2.6. By End User
7.2.7. By Distribution Channel
7.2.8. By Country
7.3. North America: Country Analysis
7.3.1. United States Nasal Drug Delivery Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Dosage Form
7.3.1.2.3. By Container Type
7.3.1.2.4. By Basis of System
7.3.1.2.5. By Therapeutic Applications
7.3.1.2.6. By End User
7.3.1.2.7. By Distribution Channel
7.3.2. Mexico Nasal Drug Delivery Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Dosage Form
7.3.2.2.3. By Container Type
7.3.2.2.4. By Basis of System
7.3.2.2.5. By Therapeutic Applications
7.3.2.2.6. By End User
7.3.2.2.7. By Distribution Channel
7.3.3. Canada Nasal Drug Delivery Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Dosage Form
7.3.3.2.3. By Container Type
7.3.3.2.4. By Basis of System
7.3.3.2.5. By Therapeutic Applications
7.3.3.2.6. By End User
7.3.3.2.7. By Distribution Channel
8. EUROPE NASAL DRUG DELIVERY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Dosage Form
8.2.3. By Container Type
8.2.4. By Basis of System
8.2.5. By Therapeutic Applications
8.2.6. By End User
8.2.7. By Distribution Channel
8.2.8. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nasal Drug Delivery Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Dosage Form
8.3.1.2.3. By Container Type
8.3.1.2.4. By Basis of System
8.3.1.2.5. By Therapeutic Applications
8.3.1.2.6. By End User
8.3.1.2.7. By Distribution Channel
8.3.2. France Nasal Drug Delivery Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Dosage Form
8.3.2.2.3. By Container Type
8.3.2.2.4. By Basis of System
8.3.2.2.5. By Therapeutic Applications
8.3.2.2.6. By End User
8.3.2.2.7. By Distribution Channel
8.3.3. United Kingdom Nasal Drug Delivery Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Dosage Form
8.3.3.2.3. By Container Type
8.3.3.2.4. By Basis of System
8.3.3.2.5. By Therapeutic Applications
8.3.3.2.6. By End User
8.3.3.2.7. By Distribution Channel
8.3.4. Italy Nasal Drug Delivery Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Dosage Form
8.3.4.2.3. By Container Type
8.3.4.2.4. By Basis of System
8.3.4.2.5. By Therapeutic Applications
8.3.4.2.6. By End User
8.3.4.2.7. By Distribution Channel
8.3.5. Spain Nasal Drug Delivery Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Dosage Form
8.3.5.2.3. By Container Type
8.3.5.2.4. By Basis of System
8.3.5.2.5. By Therapeutic Applications
8.3.5.2.6. By End User
8.3.5.2.7. By Distribution Channel
9. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Dosage Form
9.2.3. By Container Type
9.2.4. By Basis of System
9.2.5. By Therapeutic Applications
9.2.6. By End User
9.2.7. By Distribution Channel
9.2.8. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Japan Nasal Drug Delivery Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Dosage Form
9.3.1.2.3. By Container Type
9.3.1.2.4. By Basis of System
9.3.1.2.5. By Therapeutic Applications
9.3.1.2.6. By End User
9.3.1.2.7. By Distribution Channel
9.3.2. China Nasal Drug Delivery Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Dosage Form
9.3.2.2.3. By Container Type
9.3.2.2.4. By Basis of System
9.3.2.2.5. By Therapeutic Applications
9.3.2.2.6. By End User
9.3.2.2.7. By Distribution Channel
9.3.3. India Nasal Drug Delivery Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Dosage Form
9.3.3.2.3. By Container Type
9.3.3.2.4. By Basis of System
9.3.3.2.5. By Therapeutic Applications
9.3.3.2.6. By End User
9.3.3.2.7. By Distribution Channel
9.3.4. South Korea Nasal Drug Delivery Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Type
9.3.4.2.2. By Dosage Form
9.3.4.2.3. By Container Type
9.3.4.2.4. By Basis of System
9.3.4.2.5. By Therapeutic Applications
9.3.4.2.6. By End User
9.3.4.2.7. By Distribution Channel
9.3.5. Australia Nasal Drug Delivery Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Drug Type
9.3.5.2.2. By Dosage Form
9.3.5.2.3. By Container Type
9.3.5.2.4. By Basis of System
9.3.5.2.5. By Therapeutic Applications
9.3.5.2.6. By End User
9.3.5.2.7. By Distribution Channel
10. SOUTH AMERICA NASAL DRUG DELIVERY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Dosage Form
10.2.3. By Container Type
10.2.4. By Basis of System
10.2.5. By Therapeutic Applications
10.2.6. By End User
10.2.7. By Distribution Channel
10.2.8. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nasal Drug Delivery Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Dosage Form
10.3.1.2.3. By Container Type
10.3.1.2.4. By Basis of System
10.3.1.2.5. By Therapeutic Applications
10.3.1.2.6. By End User
10.3.1.2.7. By Distribution Channel
10.3.2. Argentina Nasal Drug Delivery Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Dosage Form
10.3.2.2.3. By Container Type
10.3.2.2.4. By Basis of System
10.3.2.2.5. By Therapeutic Applications
10.3.2.2.6. By End User
10.3.2.2.7. By Distribution Channel
10.3.3. Colombia Nasal Drug Delivery Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Dosage Form
10.3.3.2.3. By Container Type
10.3.3.2.4. By Basis of System
10.3.3.2.5. By Therapeutic Applications
10.3.3.2.6. By End User
10.3.3.2.7. By Distribution Channel
11. MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Dosage Form
11.2.3. By Container Type
11.2.4. By Basis of System
11.2.5. By Therapeutic Applications
11.2.6. By End User
11.2.7. By Distribution Channel
11.2.8. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Nasal Drug Delivery Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Type
11.3.1.2.2. By Dosage Form
11.3.1.2.3. By Container Type
11.3.1.2.4. By Basis of System
11.3.1.2.5. By Therapeutic Applications
11.3.1.2.6. By End User
11.3.1.2.7. By Distribution Channel
11.3.2. Saudi Arabia Nasal Drug Delivery Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Type
11.3.2.2.2. By Dosage Form
11.3.2.2.3. By Container Type
11.3.2.2.4. By Basis of System
11.3.2.2.5. By Therapeutic Applications
11.3.2.2.6. By End User
11.3.2.2.7. By Distribution Channel
11.3.3. UAE Nasal Drug Delivery Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Type
11.3.3.2.2. By Dosage Form
11.3.3.2.3. By Container Type
11.3.3.2.4. By Basis of System
11.3.3.2.5. By Therapeutic Applications
11.3.3.2.6. By End User
11.3.3.2.7. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. GlaxoSmithKline Plc.
14.2.2. Pfizer, Inc.
14.2.3. AstraZeneca PLC
14.2.4. Novartis AG
14.2.5. Becton Dickson & Company
14.2.6. Promius Pharma LLC
14.2.7. 3M Company
14.2.8. Johnson & Johnson Services, Inc.
14.2.9. Sanofi S.A.
14.2.10. Merck & Co., Inc.
14.2.11. Cadila Pharmaceuticals Ltd.
14.2.12. Aegis Therapeutics, LLC
14.2.13. B.F. Ascher & Company, Inc.
14.2.14. ENT Technologies Pty. Ltd.
14.2.15. AptarGroup, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF FIGURES
Figure 1: Global Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 3: Global Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 4: Global Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 5: Global Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 6: Global Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 7: Global Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 8: Global Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 9: Global Nasal Drug Delivery Market Share, By Company, 2020
Figure 10: Global Nasal Drug Delivery Market Share, By Region, 2016-2026F
Figure 11: Global Nasal Drug Delivery Market Share, Product Market Map, By Value, 2016-2026F
Figure 12: North America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 13: North America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 14: North America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 15: North America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 16: North America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 17: North America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 18: North America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 19: North America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 20: North America Nasal Drug Delivery, By Country, By Value, 2016-2026F
Figure 21: United States Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 22: United States Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 23: United States Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 24: United States Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 25: United States Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 26: United States Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 27: United States Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 28: United States Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 29: Mexico Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 30: Mexico Nasal Drug Delivery Market Share, By Drug Type, By Value, 2016-2026F
Figure 31: Mexico Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 32: Mexico Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 33: Mexico Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 34: Mexico Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 35: Mexico Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 36: Mexico Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 37: Canada Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 38: Canada Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 39: Canada Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 40: Canada Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 41: Canada Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 42: Canada Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 43: Canada Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 44: Canada Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 45: Europe Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 46: Europe Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 47: Europe Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 48: Europe Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 49: Europe Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 50: Europe Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 51: Europe Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 52: Europe Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 53: Europe Nasal Drug Delivery, By Country, By Value, 2016-2026F
Figure 54: Germany Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Germany Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 56: Germany Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 57: Germany Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 58: Germany Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 59: Germany Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 60: Germany Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 61: Germany Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 62: France Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 63: France Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 64: France Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 65: France Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 66: France Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 67: France Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 68: France Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 69: France Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 70: United Kingdom Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 71: United Kingdom Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 72: United Kingdom Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 73: United Kingdom Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 74: United Kingdom Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 75: United Kingdom Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 76: United Kingdom Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 77: United Kingdom Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 78: Italy Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 79: Italy Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 80: Italy Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 81: Italy Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 82: Italy Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 83: Italy Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 84: Italy Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 85: Italy Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 86: Spain Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 87: Spain Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 88: Spain Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 89: Spain Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 90: Spain Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 91: Spain Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 92: Spain Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 93: Spain Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 94: Asia-Pacific Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 95: Asia-Pacific Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 96: Asia-Pacific Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 97: Asia-Pacific Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 98: Asia-Pacific Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 99: Asia-Pacific Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 100: Asia-Pacific Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 101: Asia-Pacific Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 102: Asia-Pacific Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
Figure 103: Japan Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Japan Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 105: Japan Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 106: Japan Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 107: Japan Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 108: Japan Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 109: Japan Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 110: Japan Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 111: China Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 112: China Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 113: China Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 114: China Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 115: China Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 116: China Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 117: China Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 118: China Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 119: India Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 120: India Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 121: India Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 122: India Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 123: India Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 124: India Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 125: India Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 126: India Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 127: South Korea Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 128: South Korea Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 129: South Korea Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 130: South Korea Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 131: South Korea Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 132: South Korea Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 133: South Korea Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 134: South Korea Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 135: Australia Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 136: Australia Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 137: Australia Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 138: Australia Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 139: Australia Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 140: Australia Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 141: Australia Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 142: Australia Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 143: South America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 144: South America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 145: South America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 146: South America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 147: South America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 148: South America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 149: South America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 150: South America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 151: South America Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
Figure 152: Brazil Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 153: Brazil Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 154:
Figure 1: Global Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 3: Global Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 4: Global Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 5: Global Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 6: Global Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 7: Global Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 8: Global Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 9: Global Nasal Drug Delivery Market Share, By Company, 2020
Figure 10: Global Nasal Drug Delivery Market Share, By Region, 2016-2026F
Figure 11: Global Nasal Drug Delivery Market Share, Product Market Map, By Value, 2016-2026F
Figure 12: North America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 13: North America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 14: North America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 15: North America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 16: North America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 17: North America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 18: North America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 19: North America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 20: North America Nasal Drug Delivery, By Country, By Value, 2016-2026F
Figure 21: United States Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 22: United States Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 23: United States Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 24: United States Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 25: United States Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 26: United States Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 27: United States Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 28: United States Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 29: Mexico Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 30: Mexico Nasal Drug Delivery Market Share, By Drug Type, By Value, 2016-2026F
Figure 31: Mexico Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 32: Mexico Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 33: Mexico Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 34: Mexico Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 35: Mexico Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 36: Mexico Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 37: Canada Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 38: Canada Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 39: Canada Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 40: Canada Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 41: Canada Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 42: Canada Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 43: Canada Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 44: Canada Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 45: Europe Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 46: Europe Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 47: Europe Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 48: Europe Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 49: Europe Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 50: Europe Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 51: Europe Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 52: Europe Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 53: Europe Nasal Drug Delivery, By Country, By Value, 2016-2026F
Figure 54: Germany Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 55: Germany Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 56: Germany Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 57: Germany Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 58: Germany Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 59: Germany Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 60: Germany Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 61: Germany Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 62: France Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 63: France Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 64: France Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 65: France Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 66: France Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 67: France Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 68: France Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 69: France Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 70: United Kingdom Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 71: United Kingdom Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 72: United Kingdom Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 73: United Kingdom Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 74: United Kingdom Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 75: United Kingdom Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 76: United Kingdom Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 77: United Kingdom Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 78: Italy Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 79: Italy Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 80: Italy Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 81: Italy Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 82: Italy Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 83: Italy Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 84: Italy Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 85: Italy Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 86: Spain Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 87: Spain Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 88: Spain Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 89: Spain Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 90: Spain Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 91: Spain Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 92: Spain Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 93: Spain Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 94: Asia-Pacific Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 95: Asia-Pacific Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 96: Asia-Pacific Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 97: Asia-Pacific Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 98: Asia-Pacific Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 99: Asia-Pacific Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 100: Asia-Pacific Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 101: Asia-Pacific Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 102: Asia-Pacific Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
Figure 103: Japan Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Japan Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 105: Japan Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 106: Japan Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 107: Japan Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 108: Japan Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 109: Japan Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 110: Japan Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 111: China Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 112: China Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 113: China Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 114: China Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 115: China Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 116: China Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 117: China Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 118: China Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 119: India Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 120: India Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 121: India Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 122: India Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 123: India Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 124: India Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 125: India Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 126: India Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 127: South Korea Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 128: South Korea Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 129: South Korea Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 130: South Korea Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 131: South Korea Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 132: South Korea Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 133: South Korea Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 134: South Korea Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 135: Australia Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 136: Australia Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 137: Australia Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 138: Australia Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 139: Australia Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 140: Australia Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 141: Australia Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 142: Australia Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 143: South America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 144: South America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 145: South America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
Figure 146: South America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
Figure 147: South America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
Figure 148: South America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
Figure 149: South America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
Figure 150: South America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 151: South America Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
Figure 152: Brazil Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
Figure 153: Brazil Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
Figure 154:
